medline.ch Dermatologie Psoriasis

	Differentiation of Palmoplantar Psoriasis, Palmoplantar Pustulosis and Hyperkeratotic Palmoplantar Eczema Using Proteomic Analysis of Tape Strip Samples. Exp Dermatol Johansen MB, Altintas S, Bronze M, Woetmann A, Zachariae C, Näslund-Koch C, Løvendorf MB, Skov L. PMID: 42429051 [PubMed - indexed for MEDLINE]
	Corrigendum to "Diagnosis and therapeutic management of psoriatic arthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA)". Ther Adv Musculoskelet Dis PMID: 42428303 [PubMed]
	The Quality and Reliability of Short Videos About Psoriatic Arthritis on Bilibili and TikTok: Cross-Sectional Study. Int J Rheum Dis Tang Z, Zhao Y, Liu X. PMID: 42427234 [PubMed - in process]
	Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry. J Dermatolog Treat Rob F, Machovcová A, Jandová M, Tichý M, Vantuchová Y, Ne, Kojanová M, Cetkovská P, T, Gkalpakiotis S. PMID: 42427208 [PubMed - indexed for MEDLINE]
	A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score. PLoS One Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, Nong Y, Armstrong AW. PMID: 42424368 [PubMed - indexed for MEDLINE]
	Association Between Psoriasis and Prostate Cancer Risk in Men: A Retrospective Cohort Study. J Epidemiol Glob Health Lai SW, Liao KF. PMID: 42423818 [PubMed - as supplied by publisher]
	Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio region. Drugs Context Feresin F, Bernardini N, Campione E, Caldarola G, Gubinelli E, Moretta G, Pagnanelli G, Giordano D, Persechino S, Falco GM, Artosi F, Zappia E, Pellacani G, Potenza C, Richetta AG, De Simone C, Orsini D, Dattola A. PMID: 42422714 [PubMed]
	The therapeutic potential of natural products for pediatric psoriasis: targeting the immune microenvironment. Front Pediatr Wang Z, Zhang J, Liu S, Chen H. PMID: 42422443 [PubMed]
	Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods. Pharmacoeconomics Clemmet TS, Phan DB, Copson A, Warren RB, Yiu ZZN, Rogers G. PMID: 42420624 [PubMed - as supplied by publisher]
	Harnessing Administrative Data for Real-World Evidence in Psoriatic Disease: Opportunities, Challenges, and Methodological Considerations. J Rheumatol McGagh D, Macfarlane GJ, Ogdie A. PMID: 42414045 [PubMed - as supplied by publisher]
	Pediatric Psoriasis: Comorbidities, Treatment Challenges and Unmet Needs. Dermatol Ther (Heidelb) Hernández-Santacana M, Balado-Simó P, Mansilla-Polo M, Riera-Monroig J. PMID: 42410289 [PubMed - as supplied by publisher]
	Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort. Pediatr Dermatol Rached A, Miao Y, Beauchet A, Piram M, McPherson T, Torres T, Yesli Y, Aubert H, Bodemer C, Bertoli C, Tardieu M, Hubiche T, Bonniaud B, Neri I, Chessa MA, Lasek A, Prignano F, Barbarot S, Bursztejn AC, Leducq S, Sergeant M, Puzenat E, Chiaverini C, Sigg N, Mallet S, Miquel J, Pourchot D, Patel KX, Burden-Teh E, Flohr C, Di Lernia V, Mahé E, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, GrPso of the Société Française de Dermatologie. PMID: 42409581 [PubMed - as supplied by publisher]
	Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up. PLoS One Attar RZ, Movahedi M, Cesta A, Li X, Sabido-Sauri R, Tsechelidis OB, Lau A, Chow A, Thorne C, Haaland D, Soucy E, Bombardier C, Aydin SZ, OBRI Investigators. PMID: 42406812 [PubMed - indexed for MEDLINE]
	Psoriatic arthritis patients have increased morbidity already at the time of diagnosis: a case-control study. Rheumatol Int Laine A, Muilu P, Kautiainen H, Rantalaiho V. PMID: 42406116 [PubMed - indexed for MEDLINE]
	Intelligent Diagnosis and Treatment of Psoriasis Research: A Bibliometric Analysis from 2005-01-01 to 2025-12-31. Clin Cosmet Investig Dermatol Jiang S, Tian Y, Zhao Q, Chen C, Lu T, Xiang Y. PMID: 42405326 [PubMed]
	Repurposing Old Drugs: Roflumilast as a Promising Therapeutic Option for Plaque Psoriasis. Clin Cosmet Investig Dermatol Li S, Wu N, Liu X, Jiang W. PMID: 42405325 [PubMed]
	Investigating the relationship between psoriatic arthritis, multiple long-term conditions, treatment burden and adverse clinical outcomes: A systematic review protocol. J Multimorb Comorb Opoku-Pare GA, Jani BD, Siebert S, Mair FS, Booth I, Canning J, Nicholl BI. PMID: 42404215 [PubMed]
	A Systematic Literature Review on Methotrexate Hepatotoxicity in Psoriasis Management: Preconceived Notion or Real Threat? Acta Derm Venereol Boehncke WH, Constantin MM, Carrascosa-Carrillo JM, Rakvit P, Varlet AA, Le Clanche S, Verhagen LAW, Viguier M. PMID: 42403312 [PubMed - indexed for MEDLINE]
	Comparative Transcriptomics Reveals SKH-1 Mice as a Valuable Model for Psoriasis Pathogenesis and Recurrence Studies. Exp Dermatol Yue L, Bai Y, Pang B, Qiao P, Xue K, Hu L, Wang G, Dang E. PMID: 42402932 [PubMed - indexed for MEDLINE]
	Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study. J Am Acad Dermatol Xue Y. PMID: 42398781 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 28193

Seite 1 von 1410

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung